275 filings
Page 2 of 14
NT 10-K
apnq 8cn233
29 Feb 24
Notice of late annual filing
8:19am
8-K
1s4n0
29 Feb 24
Results of Operations and Financial Condition
8:17am
8-K
e3fwa g563
29 Feb 24
Departure of Directors or Certain Officers
8:14am
8-K/A
202p yazx
16 Feb 24
Departure of Directors or Certain Officers
4:17pm
8-K
kkgdf gfls1243wu9k
16 Feb 24
Chemours Announces Changes to its Board of Directors
4:16pm
8-K
4jjsbzu phz0
13 Feb 24
Chemours Reschedules Earnings Release and Conference Call
4:19pm
UPLOAD
4nav4zrztf
10 Jan 24
Letter from SEC
12:00am
CORRESP
3cnm ktsm9j6304w2f
8 Jan 24
Correspondence with SEC
12:00am
UPLOAD
y6e4n9295tvedq6
3 Jan 24
Letter from SEC
12:00am
CORRESP
sb7ge3c
22 Dec 23
Correspondence with SEC
12:00am
UPLOAD
e279z7
13 Dec 23
Letter from SEC
12:00am
8-K
t5n1a a1tmtvz
29 Nov 23
Chemours Announces Settlement Agreement with State of Ohio
6:49am
8-K
o9ccmmg3xlo r2
22 Nov 23
The Chemours Company Announces Changes to its Board of Directors
4:11pm
8-K
ybm6q1q ufk
26 Oct 23
The Chemours Company Announces Third Quarter 2023 Results
4:20pm
8-K
zcwi jzjx5zugwpu253
23 Aug 23
Entry into a Material Definitive Agreement
5:23pm
8-K
hhudm3q
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am
8-K
wr1enhkw5mpvoym8slj
27 Jul 23
The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan
9:01pm
8-K
hrqo0 qorwkbms5u74
26 Jul 23
Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions
7:47am